GLPwatch
Papers (10409)
Page 129 of 174, ranked by citation count.
- Early onset of acute pancreatitis in a patient on low-dose liraglutide.
- Patient experiences with group consultations when treated with semaglutide for obesity: a qualitative case study in a Danish general practice.
- Effect of the GLP-1 receptor agonist exenatide on pro-inflammatory and metabolic biomarkers in individuals with alcohol use disorder: Post hoc results from a randomized, double-blinded, placebo-controlled clinical trial.
- An Overview of the Burden of Illness and the Role of Once-Weekly Glucagon-like Peptide-1 Receptor Agonists in the Treatment of Type 2 Diabetes.
- [Liraglutide and glimepiride on glycaemic control in type 2 diabetes in the Mexican cohort (LEAD 3)].
- More on Semaglutide in Early Type 1 Diabetes.
- Nutritional status with tirzepatide in obesity: A post hoc analysis of the SURMOUNT-1-4 randomized clinical trials.
- Multivalent γ-PGA-Exendin-4 Conjugates to Target Pancreatic β-Cells.
- [Incretin therapy and the metabolic syndrome].
- Effects of exenatide in a morbidly obese patient with type 2 diabetes.
- Clinical Effectiveness of Oral Semaglutide in Women with Type 2 Diabetes: A Nationwide, Multicentre, Retrospective, Observational Study (Women_ENDO2S-RWD Substudy).
- Differential effects of liraglutide naltrexone/bupropion, and caloric restriction on metabolic parameters and beta-cell regeneration in type 2 diabetic rat model: role of beta arrestin 1.
- Effects of Tirzepatide on Skeletal Muscle Mass in Adults: A Systematic Review.
- In brief: GI effects of GLP-1 receptor agonists.
- Possible protective effects of tirzepatide on polycystic ovary syndrome in female rat model induced by testosterone propionate in comparison to metformin.
- Exploring the Effects of Tirzepatide on Obstructive Sleep Apnea: A Literature Review.
- Metabolic resilience: liraglutide's potential in alleviating depressive symptoms.
- Incretin based therapeutics: connections to vascular biology and implications for potential cardiovascular disease prevention: Editorial to: "Glucagon-like peptide-1 receptor agonist liraglutide inhibits endothelin-1 in endothelial cell by repressing nuclear factor-kappa B activation" by Dai et al.
- Exenatide once weekly: opportunities in the primary care setting.
- Indirectly radioiodinated exendin-4 as an analytical tool for in vivo detection of glucagon-like peptide-1 receptor in a disease setting.
- Inclusion of drugs on the World Health Organization's Essential Medicines List: A game-changer for obesity?
- Is liraglutide safe and effective in the elderly obese patients?: A single center experience.
- A case of euglycaemic diabetic ketoacidosis in a T2DM patient using Tirzepatide.
- Assessing the therapeutic potential of Tirzepatide in modulating inflammatory responses and mitigating acute pancreatitis.
- The weight-loss-independent hepatoprotective benefits of semaglutide are orchestrated by intrahepatic sinusoidal endothelial GLP-1 receptors.
- Short-term cost-effectiveness of oral semaglutide for the treatment of type 2 diabetes mellitus in the United States.
- Effects of glucagon-like peptide-1 receptor agonists on male reproductive hormones, semen parameters, and metabolic outcomes: a systematic review.
- The safety and efficacy of liraglutide combined with metformin in clinical treatment of polycystic ovary syndrome patients: a meta-analysis.
- Semaglutide and Heart Failure with Preserved Ejection Fraction and Obesity.
- Cardiovascular safety of liraglutide for the treatment of type 2 diabetes.
- Exenatide and Metformin Improve Serum Indices and Intestinal Flora in patients with Type 2 Diabetes Mellitus and Non-Alcoholic Fatty Liver Disease.
- Older Adults' Views on Insurance Coverage for Weight Management Medications.
- Fabrication and Preclinical Evaluation of Hyaluronic Acid/Aminoclay Nanocomposite Microneedles for Noninvasive Delivery of Semaglutide in Anti-Obesity Therapy.
- Multi-pathway-driven hepatic protection: Semaglutide combined with HIIT counteracts diabetic liver injury in db/db mice.
- Effect of pH, buffers, molarity, and temperature on solution state degradation of semaglutide using LC-HRMS: A preformulation protocol for peptide drug delivery.
- GLP-1 Receptor Agonist Orforglipron for Adults with Obesity.
- Interaction Between Glucagon-like Peptide 1 and Its Analogs with Amyloid-β Peptide Affects Its Fibrillation and Cytotoxicity.
- Potent synergistic effects of dulaglutide and food restriction in prevention of olanzapine-induced metabolic adverse effects in a rodent model.
- Therapeutic Potential of the Novel GLP-1 Receptor Agonist Semaglutide in Alcohol Use Disorder.
- Semaglutide reduces the absolute risk of major cardiovascular events by 1.5.
- Ischemic optic neuropathy with semaglutide: global observational analysis of sex- and formulation-specific risk.
- Superior Cerebrovascular Outcomes with Tirzepatide Versus Semaglutide: A Call for Cautious Interpretation of Observational Data.
- Retatrutide improves steatohepatitis in an accelerated mouse model of diet-induced steatohepatitis with a fructose binge.
- Effects of 3-month liraglutide treatment on oxidative stress and inflammation in type 2 diabetes patients with different urinary albumin-to-creatinine ratio categories.
- Impact of Semaglutide 2.4 mg on Healthcare Resource Utilization and Medical Costs in Patients With Heart Failure in the United States (SHINE-HF).
- Treatment of Metabolic (Dysfunction)-Associated Fatty Liver Disease: Evidence from Randomized Controlled Trials-A Short Review.
- [Cardiovascular effects of GLP-1 receptor agonist treatment: focus on liraglutide].
- Tirzepatide for metabolic dysfunction-associated steatohepatitis: results from phase II clinical trials and perspectives.
- Does Semaglutide Reduce Kidney Disease Events on Top of SGLT2 Inhibitors in Patients with CKD and T2D?
- Melatonin, Liraglutide, and Naltrexone/Bupropion for the Treatment of Obesity and Medication-Related Weight Gain.
- [Why is a combination of basal insulin with a GLP-1 receptor agonist useful in many patients with type 2 diabetes?]
- A LEADER in the management of type 2 diabetes and cardiorenal disease.
- [Effect of liraglutide on glucagon secretion in obese type 2 diabetic patients].
- Semaglutide reduces murine blood pressure through the vascular smooth muscle GLP-1 receptor.
- Oxyntomodulin attenuates exendin-4-induced hypoglycemia in cattle.
- Periconceptional GLP-1 receptor agonist exposure and obstetric outcomes: a Danish nationwide cohort study.
- The Long-Term Cost-Effectiveness of Tirzepatide 5 mg versus Dulaglutide 0.75 mg for the Treatment of People with Type 2 Diabetes in Japan.
- [Effect of Liraglutide on platelet distribution width and carotid intima-media thickness in type 2 diabetic mellitus patients with obesity].
- Editorial commentary: Weight loss for cardiovascular disease prevention - is semaglutide the answer?
- A call to update anesthetic protocols: the hidden risks of semaglutide.